Telmisartan and Clindamycin phosphate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Telmisartan and Clindamycin phosphate together.
The phase IV clinical study analyzes what interactions people who take Telmisartan and Clindamycin phosphate have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Telmisartan and Clindamycin phosphate together, and have interactions are studied.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 4,343 Telmisartan users for its effectiveness, alternative drugs and more.
What is Clindamycin phosphate?
Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,458 Clindamycin phosphate users for its effectiveness, alternative drugs and more.
Number of Telmisartan and Clindamycin phosphate reports submitted per year:
Common Telmisartan and Clindamycin Phosphate drug interactions by gender *:
female:
- Interstitial lung disease
male:
- Alopecia
- Apnoea
- Headache
- Immune system disorder
- Nail disorder
- Sinus disorder
- Snoring
Common Telmisartan and Clindamycin Phosphate drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Alopecia
- Apnoea
- Headache
- Immune system disorder
- Interstitial lung disease
- Nail disorder
- Sinus disorder
- Snoring
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and Clindamycin phosphate?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Telmisartan (4,343 reports)
- Clindamycin phosphate (3,458 reports)
Browse all drug interactions of Telmisartan and Clindamycin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Telmisartan side effects:
- High blood pressure: 422 reports
- Fatigue (feeling of tiredness): 314 reports
- Diarrhea: 276 reports
- Drug ineffective: 253 reports
- Breathing difficulty: 239 reports
- Weakness: 231 reports
- Dizziness: 228 reports
- Headache (pain in head): 216 reports
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Clindamycin phosphate side effects:
- Rashes (redness): 317 reports
- Drug ineffective: 283 reports
- Diarrhea: 193 reports
- Fever: 159 reports
- Fatigue (feeling of tiredness): 158 reports
- Pain: 152 reports
- Breathing difficulty: 114 reports
- Pneumonia: 113 reports
Browse all side effects of Clindamycin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Telmisartan interactions:
- Telmisartan and Amlodipine: 833 reports
- Telmisartan and Aspirin: 749 reports
- Telmisartan and Metformin: 564 reports
- Telmisartan and Pantoprazole: 438 reports
- Telmisartan and Hydrochlorothiazide: 411 reports
- Telmisartan and Furosemide: 410 reports
- Telmisartan and Prednisone: 372 reports
- Telmisartan and Acetaminophen: 345 reports
- Telmisartan and Methotrexate: 338 reports
- Telmisartan and Amlodipine besylate: 302 reports
Browse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Clindamycin phosphate interactions:
- Clindamycin phosphate and Omeprazole: 234 reports
- Clindamycin phosphate and Vitamin d: 216 reports
- Clindamycin phosphate and Xyrem: 213 reports
- Clindamycin phosphate and Aspirin: 202 reports
- Clindamycin phosphate and Doxycycline: 190 reports
- Clindamycin phosphate and Prednisone: 189 reports
- Clindamycin phosphate and Gabapentin: 177 reports
- Clindamycin phosphate and Metformin: 159 reports
- Clindamycin phosphate and Metronidazole: 150 reports
- Clindamycin phosphate and Furosemide: 148 reports
Browse all interactions between Clindamycin phosphate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on telmisartan and clindamycin phosphate (the active ingredients of Telmisartan and Clindamycin phosphate, respectively), and Telmisartan and Clindamycin phosphate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Telmisartan and Clindamycin phosphate.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Leflunomide and Drug Resistance - 4 seconds ago
- Multaq and Upper Gastrointestinal Haemorrhage - 10 seconds ago
- Clotrimazole and Neutrophil Count Increased - 12 seconds ago
- Lexapro and Hydroxyzine Pamoate drug interaction - 13 seconds ago
- Zantac and Erection Increased (Exc Priapism) - 14 seconds ago
- Sudafed 12 Hour and Asthma - 17 seconds ago
- Seasonale and Injury - 19 seconds ago
- Valtrex and Eosinophil Count Decreased - 20 seconds ago
- Magnesium Oxide and Frustration - 21 seconds ago
- Meniere'S Disease and Constipation - 22 seconds ago